

Cover Story
NCI
By Claire Marie Porter and Paul Goldberg
Anthony G. Letai, a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute whose research is focused on apoptosis and functional diagnostics, has been tapped by the Trump administration to become the 18th director of the National Cancer Institute.
Cancer Policy
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
Trending Stories
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - NCI releases names of members of ad hoc working group—filling the void left by BSA
- Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer
- ACOG says it will no longer accept federal funding
- NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium
- Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes.